Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 231-241

  Corsetti, James P ^a   Sparks, Janet D ^a   Peterson, Richard G ^b   Smith, Robert L ^c   Sparks, Charles E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Animal models; Dyslipidemia; High fat diet; Non insulin dependent diabetes mellitus (NIDDM); ZDF Gmi(TM) fa; Zucker diabetic fatty

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FAT INTAKE; FEMALE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RAT STRAIN; SEX DIFFERENCE;

ANIMALS; APOLIPOPROTEINS B; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; MALE; OBESITY; RATS; RATS, ZUCKER; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0033972763     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00265-8     Document Type: Article

References (52)

1. Chua S.C., Chung W.K., Wu-Peng X.S., Zhang Y., Liu S.M., Tartaglia L. et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271:1996;994-996.
2. Philips M.S., Liu Q., Hammond H.A., Dugan V., Hey P.J., Caskey C.T. et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:1996;18-19.
3. Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 222:1996;19-26.
4. Iida M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Substitution at codon 269 (glutamine to proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 224:1996;597-604.
5. Takaya K., Ogawa Y., Isse N., Okazaki T., Satoh N., Masuzaki H. et al. Molecular cloning of rat leptin receptor isoform complementary DNA′ - identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 225:1996;75-83.
6. Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 8:1992;179-208.
7. Peterson R.G., Shaw W.N., Neel M.A., Little L.A., Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News. 32:1990;16-19.
8. Clark J.B., Palmer C.J., Shaw W.N. The diabetic Zucker fatty rat (41611). Proc. Soc. Exp. Bio. Med. 173:1983;68-75.
9. m glucose transporters in non-insulin-dependent diabetes. Science. 250:1990;546-549.
10. Peterson RG, Neel MA, Little LA, Kincaid JC, Eichberg J. Neuropathic complications in the Zucker diabetic fatty rat, In: Shafrir E, editor. Frontiers in diabetic research. Lessons From animal diabetes III. Smith-Gordon, 1990. p. 456-458.
11. Danis R.P., Yang Y. Microvascular retinopathy in the Zucker diabetic fatty rat. Invest. Ophthalmol. Vis. Sci. 34:1993;2367-2371.
12. Orci L., Ravazzola M., Baetens D., Inman L., Amherdt M., Peterson R.G. et al. Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. Proc. Natl. Acad. Sci. USA. 87:1990;9953-9957.
13. Unger R.H. Role of impaired glucose transport by beta-cells in the pathogenesis of diabetes. J. NIH Res. 3:1991;77-80.
14. Unger R.H. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta-cells. Science. 251:1991;1200-1205.
15. Ohneda M., Johnson J.H., Lee Y.H., Nagasawa Y., Unger R.H. Post-GLUT-2 defects in beta-cells of non-insulin dependent diabetic obese rats. Am. J. Physiol. 267:1994;E968-E974.
16. Pieber T.R., Stein D.T., Ogawa A., Alam T., Ohneda M., McCorkle K. et al. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am. J. Physiol. 265:1993;E446-E453.
17. Lee Y., Hirose H., Ohneda M., Johnson J.H., McGarry J.D., Unger R.H. b Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte beta-cell relationships. Proc. Natl. Acad. Sci. USA. 91:1994;10878-10882.
18. Lee Y., Hirose H., Zhou Y.T., Esser V., McGarry J.D., Unger R.H. Increased lipogenic capacity of the islets of obese rats. Diabetes. 46:1997;408-413.
19. Peterson R.G. a-Glucosidase inhibitors in diabetes: lessons from animal studies. Eur. J. Clin. Invest. 24(Suppl 3):1994;11-18.
20. Peterson R.G., Shaw W.N., Little L.A., Pesek J.F. The obese female ZDF rat as an inducible NIDDM model. Obesity Res. 3((Suppl. 3)):1995;362s. (abstract).
21. Sparks J.D., Sparks C.E., Bolognino M., Roncone A.M., Jackson T.K., Amatruda J.M. Effects of non-ketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes. J. Clin. Invest. 82:1988;37-43.
22. Unger R.H., Foster D.W. Diabetes mellitus. Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. Williams textbook of endocrinology. 1998;1010 Saunders, Philadelphia, PA.
23. Sparks J.D., Phung T.L., Bolognino M., Cianci J., Khurana R., Peterson R.G. et al. Lipoprotein alterations in 10- and 20-week old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia. Metabolism. 47:1998;1315-1324.
24. Haffner S.M., Mykkanen L., Stern M.P., Paidi M., Howard B.V. Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 17:1994;1164-1171.
25. Musliner T., McVicker K.M., Iosefa J.F., Krauss R.M. Metabolism of human IDL and VLDL subfractions from normal and dysbetalipoproteinemic plasma. Arteriosclerosis. 7:1987;408-420.
26. Krauss R.M. Relationship of IDL and LDL subspecies to risk of coronary artery disease. Am. Heart J. 113:1987;578-582.
27. Lewis G.F., Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in NIDDM. Diabetes Metab. Rev. 12:1996;37-56.
28. Balon T.W., Gu J.L., Tokuyama Y., Jasman Q.P., Nadler J.L. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 269:1995;E745-E752.
29. Rasschaert J., Malaisse-Lagae F., Sener A., Leclercq-Meyer V., Herberg L., Malaisse W.J. Impaired FAD-glycerophosphate dehydrogenase activity in islet and liver homogenates of fa/fa rats. Mol. Cell. Biochem. 135:1994;137-141.
30. Ohlson L.O., Larsson B., Bjorntorp P., Eriksson H., Svardsudd K., Welin L. et al. Risk factors for type 2 diabetes mellitus. Diabetologia. 31:1988;798-805.
31. Pollare T., Vessby B., Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler. Thromb. 11:1991;1192-1203.
32. Gross G., Sykes M., Arellano R., Fong B., Angel A. HDL clearance and receptor-mediated catabolism of LDL are reduced in hypothyroid rats. Atherosclerosis. 66:1987;269-275.
33. Castells S. Thyroid function in juvenile diabetes. Pediatr. Clin. North Am. 31:1984;623-634.
34. Cavalieri R.R. The effects of non-thyroid disease and drugs on thyroid function tests. Med. Clin. North Am. 75:1991;27-39.
35. McCarty M.F. Central insulin may up-regulate thyroid activity by suppressing neuropeptide y release in the paraventricular nucleus. Med. Hypothesis. 45:1995;193-199.
36. Marshall J.A., Hamman R.F., Baxter J. High-fat, low-carbohydrate diet and the etiology of NIDDM: the San Luis Valley Diabetes Study. Am. J. Epidemiol. 134:1991;590-603.
37. Kromhout K., Feskens E.J.M. Nutrition and diabetes: the role of fat. Acta Cardiol. 48:1993;444-445.
38. Mayer E.J., Newman B., Quesenberry C.P., Selby J.V. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care. 16:1993;1459-1469.
39. Marshall J.A., Hoag S., Shetterly A., Hamman R.F. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. Diabetes Care. 17:1994;50-56.
40. Hannah J.S., Howard B.V. Dietary fats, insulin resistance, and diabetes. J. Cardiovasc. Risk. 1:1994;31-37.
41. Vessby B. Nutrition, lipids and diabetes mellitus. Curr. Opin. Lipidol. 6:1995;3-7.
42. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes. 44:1995;863-870.
43. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta-cell apoptosis: a link between obesity and diabetes. Proc. Nat. Acad. Sci. USA. 95:1998;2498-2502.
44. Wang M.Y., Koyama K., Shimabukuro M., Newgard C.B., Unger R.H. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Nat. Acad. Sci. USA. 95:1998;714-718.
45. Holden R.J. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders. Med. Hypotheses. 45:1995;169-189.
46. Bjorntorp P. Androgens, the metabolic syndrome, and NIDDM. Ann. New York Acad. Sci. 676:1993;242-252.
47. Knopp R.H., Zhu X., Bonet B. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis. 110((Suppl.)):1994;S83-S91.
48. Paolisso G., Rizzo M.R., Mone C.M., Tagliamonte M.R., Gambardella A., Riondino M. et al. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects. Clin. Endocrinol. 48:1988;291-297.
49. Mannucci E., Ognibene A., Becorpi A., Cremasco F., Pellegrini S., Ottanelli S. et al. Relationship between leptin and oestrogens in healthy women. Eur. J. Endocrinol. 139:1998;198-201.
50. Behre H.M., Simoni M., Nieschlag E. Strong association between serum levels of leptin and testosterone in men. Clin. Endocrinol. 47:1997;237-240.
51. Ambrosius W.T., Compton J.A., Bowsher R.R., Pratt J.H. Relation of race, age, and sex hormone differences to serum leptin concentrations in children and adolescents. Horm. Res. 49:1998;240-246.
52. Haffner S.M., Miettinen H., Karhapaa P., Mykkanen L., Laakso M. Leptin concentrations, sex hormones and cortisol in non-diabetic men. J. Clin. Endocrinol. Met. 82:1997;1807-1809.